Enterprise Ventures
VC Fund
Preston, United Kingdom
Enterprise Ventures (EV) is a leading providers of venture capital and early stage finance to SMEs in England and Wales, and one of the few able to provide both equity and debt funding.EV has a wide range of investment funds which it manages on behalf of investor clients from both the private and public sector. It invests sums of up to£2million in businesses at all stages of development, from pre-revenue & proof of concept, through to MBO/MBI opportunities and development and replacement capital.EV is regulated by the Financial Services Authority (FSA) and are full members of the British Venture Capital Association (BVCA).
- Total investments:
- 16
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Enterprise Ventures invests in
Stages Enterprise Ventures invests in
Countries Enterprise Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Post-IPO Equity
- $524k–$5.1M
Investment Focus
Industry
- Biotechnology 4 (25%)
- Health Care 3 (19%)
- Medical 2 (13%)
- Software 2 (13%)
- Biopharma 2 (13%)
Stage
- Funding Round 10 (63%)
- Seed 2 (13%)
- Post-IPO Equity 2 (13%)
- Series A 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Ashwin Kumaraswamy
Investment Manager
|
Investment Manager | Total investments: 4 | Find email | |
Clive Downward
Investment Director
|
Investment Director | Total investments: 0 | Find email | |
Grahame Lunt
Investment Manager
|
Investment Manager | Total investments: 1 | Find email | |
Ian Atkinson
Investment Manager
|
Investment Manager | Total investments: 0 | Find email | |
John Simpson
Finance Director
|
Finance Director | Total investments: 0 | Find email | |
| See all 12 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Plant Impact
|
Their products manage a plant’s natural responses to stress factors to build its resilience. This boost in strength helps the plant to flourish in good conditions but also when faced with increasingly common stresses such as heat, salinity, drought and the application of other chemicals.Their head office and primary research facility are at theRothamsted Centre for Research and Enterprise (RoCRE) in Harpenden, UK and they have additional offices in Brazil, USA and Argentina as well as colleagues based in Turkey and France. | $5.1M / Post-IPO Equity / Aug 23, 2017 | |
Blue-i Event Technology
|
Blue-i Event Technology specialising in the supply of Audio Visual Services to the events industry. | Jun 21, 2016 | |
Concepta PLC
|
Concepta PLC is involved in the development of products and a platform, which targets the personalized mobile health market with a focus on women’s fertility and unexplained infertility. | $524K / Post-IPO Equity / May 09, 2016 | |
Woodall Nicholson Group
|
Woodall Nicholson is one of the oldest established coachbuilding companies in the UK, dating right back to the 1820′s, when its major market was the building of horse-drawn hansom cabs and carriages. | Jul 19, 2013 | |
Xeros
|
Xeros Ltd. is a new company focused on the development of "virtually waterless" laundry cleaning. Harnessing over 30 years of research by Professor Stephen Burkinshaw and the University of Leeds, Xeros is the brand name for a patented polymer based cleaning that creates step change advantage in the cost and environmental impact of aqueouswash cleaning. | $13.1M / Mar 13, 2013 | |
TyresOnTheDrive.com
|
TyresOnTheDrive is a mobile tyre-fitting company that allows customers to book online or over the phone and have new tyres fitted, or punctures repaired, at any suitable location of their choice, whether that's at home, at work or even at the gym! They’re proud to be different: they’ve long believed that the purchase and fitting of tyresdoesn’t have to be a drawn out, inconvenient and laborious process where the customer has to fit around the static hours of a garage.Their mobile fitting units make sitting around in a cold garage a thing of the past. Now you can be at home or at a work getting on with the things that are important to you, while their expert technicians deal with your tyre fitting. | $815K / Feb 06, 2013 | |
Peckforton Pharmaceuticals
|
Peckforton Pharmaceuticals Ltd. is a fast growing, dynamic speciality pharmaceutical company that manufactures, distributes and sells prescription and OTC products in the UK and Europe.The company is focused into two divisions, Branded and Hospital. Each division has distinct and separate requirements to support both the patient and the healthcareprofessional, with the primary focus on ensuring and maintaining the ‘quality of supply’ and the ‘quality of medicine’. | $1.3M / Mar 02, 2012 | |
Biofortuna
|
Biofortuna provides molecular diagnostics services. It manufactures HLA and ABO genotyping product families for the transplantation and haematology markets. The company is also developing antibody screening, genotyping and phenotyping products, software for genotyping applications, transplant monitoring, and platforms for clinical laboratories,research centers and point-of-care customers. In addition, Biofortuna Ltd. provides genotyping and custom assay development services. The company was incorporated in 2008 and is based in Liverpool, the United Kingdom. | $1.7M / Jan 01, 2012 | |
Altacor
|
Altacor develops and brings to market specialist ophthalmic products designed for the needs of both ophthalmologists and patients.Altacor brings together skills in drug development with in-depth market knowledge and an understanding of the European regulatory environment, to create a portfolio of high quality, differentiated prescriptionmedicines that set new standards in the sector.Altacor's pipeline includes products for dry-eye, glaucoma, glaucoma surgery and ocular surgery. | $2.4M / Feb 09, 2011 | |
eoSemi
|
eoSemi is an emerging privately-funded semiconductor product company based in South Yorkshire.Shrinking electronic systems are placing significant pressure on traditional timing and frequency devices to reduce in size without compromising performance - something they cannot do easily or cheaply.eoSemi is a new technological transformation.It meets head-on the challenges of size-vs-performance, with an enabling technology that allows for creation of far more compact designs, and that facilitates new classes of product and application. | $4.5M / Jun 25, 2010 | |
| See all 16 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Enterprise Ventures invest in?
Enterprise Ventures invests primarily in Biotechnology, Health Care and Medical startups, most often at Funding Round and Seed stage. Most of the 16 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Enterprise Ventures's check size?
Enterprise Ventures typically joins rounds of $524k–$5.1M at Post-IPO Equity. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Enterprise Ventures participates in.
How do I contact Enterprise Ventures?
Public channels for Enterprise Ventures include X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Enterprise Ventures?
The team at Enterprise Ventures includes Ashwin Kumaraswamy (Investment Manager), Clive Downward (Investment Director) and Grahame Lunt (Investment Manager), among 12 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
